Phase II study of autologous mRNA electroporated dendritic cells (TriMixDC-MEL) in combination with Ipilimumab in patients with pretreated advanced melanoma

समान संसाधन

• Characterization of CD8(+) T-Cell Responses in the Peripheral Blood and Skin Injection Sites of Melanoma Patients Treated with mRNA Electroporated Autologous Dendritic Cells (TriMixDC-MEL)
  द्वारा: Benteyn, Daphné, और अन्य
  प्रकाशित: (2013)
• Clinical trials with MRNA electroporated dendritic cells for stage III/IV melanoma patients
  द्वारा: Wilgenhof, Sofie, और अन्य
  प्रकाशित: (2015)
• TriMix and tumor antigen mRNA electroporated dendritic cell vaccination plus ipilimumab: link between T-cell activation and clinical responses in advanced melanoma
  द्वारा: De Keersmaecker, Brenda, और अन्य
  प्रकाशित: (2020)
• Patterns of Response in Patients with Pretreated Metastatic Melanoma who Received Ipilimumab 3 mg/kg in a European Expanded Access Program: Five Illustrative Case Reports
  द्वारा: Wilgenhof, Sofie, और अन्य
  प्रकाशित: (2012)
• Dendritic Cells Loaded With mRNA Encoding Full-length Tumor Antigens Prime CD4(+) and CD8(+) T Cells in Melanoma Patients
  द्वारा: Van Nuffel, An MT, और अन्य
  प्रकाशित: (2012)